{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:57:23Z","timestamp":1790866643574,"version":"4.1.0"},"reference-count":57,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:p>Uterine leiomyomata (ULs) represent the most common tumor in women and can cause abnormal uterine bleeding, large pelvic masses, and recurrent pregnancy loss. Although the dependency of UL growth on ovarian steroids is well established, the relative contributions of 17\u03b2-estradiol and progesterone are yet to be clarified. Conventionally, estradiol has been considered the primary stimulus for UL growth, and studies with cell culture and animal models support this concept. In contrast, no research model has clearly demonstrated a requirement of progesterone in UL growth despite accumulating clinical evidence for the essential role of progesterone in this tumor. To elucidate the functions of ovarian steroids in UL, we established a xenograft model reflecting characteristics of these tumors by grafting human UL tissue beneath the renal capsule of immunodeficient mice. Leiomyoma xenografts increased in size in response to estradiol plus progesterone through cell proliferation and volume increase in cellular and extracellular components. The xenograft growth induced by estradiol plus progesterone was blocked by the antiprogestin RU486. Furthermore, the volume of established UL xenografts decreased significantly after progesterone withdrawal. Surprisingly, treatment with estradiol alone neither increased nor maintained the tumor size. Although not mitogenic by itself, estradiol induced expression of progesterone receptor and supported progesterone action on leiomyoma xenografts. Taken together, our findings define that volume maintenance and growth of human UL are progesterone dependent.<\/jats:p>","DOI":"10.1210\/en.2009-1225","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T21:58:12Z","timestamp":1270677492000},"page":"2433-2442","source":"Crossref","is-referenced-by-count":314,"title":["Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma"],"prefix":"10.1210","volume":"151","author":[{"given":"Hiroshi","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Division of Reproductive Biology Research, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutomo","family":"Ishi","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanida Ann","family":"Serna","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Kakazu","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar E.","family":"Bulun","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurita","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,4,7]]},"reference":[{"key":"2020071613353936600_R1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.","volume":"188","author":"Day Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613353936600_R2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas.","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"2020071613353936600_R3","first-page":"CR24","article-title":"through 2005","volume":"14","year":"1997","journal-title":"Med Sci Monit"},{"key":"2020071613353936600_R4","first-page":"2192","article-title":"Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.","volume":"83","author":"Shimomura","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613353936600_R5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/09513590801893315","article-title":"Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells.","volume":"24","author":"Park","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"2020071613353936600_R6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1095\/biolreprod52.4.824","article-title":"Estrogen-induced guinea pig model for uterine leiomyomas: do the ovaries protect?","volume":"52","author":"Porter","year":"1995","journal-title":"Biol Reprod"},{"key":"2020071613353936600_R7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat.","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol Reprod"},{"key":"2020071613353936600_R8","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1210\/endo.136.11.7588234","article-title":"Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo.","volume":"136","author":"Howe","year":"1995","journal-title":"Endocrinology"},{"key":"2020071613353936600_R9","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1210\/endo.137.6.8641172","article-title":"Functional and growth properties of a myometrial cell line derived from transgenic mice: effects of estradiol and antiestrogens.","volume":"137","author":"Blin","year":"1996","journal-title":"Endocrinology"},{"key":"2020071613353936600_R10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","article-title":"17\u03b2-Estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway.","volume":"186","author":"Barbarisi","year":"2001","journal-title":"J Cell Physiol"},{"key":"2020071613353936600_R11","first-page":"36","article-title":"Growth potential of human uterine leiomyomas: some in vitro observations and their implications.","volume":"66","author":"Cramer","year":"1985","journal-title":"Obstet Gynecol"},{"key":"2020071613353936600_R12","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/endo.141.10.7719","article-title":"In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine\/intracrine mechanism.","volume":"141","author":"Sumitani","year":"2000","journal-title":"Endocrinology"},{"key":"2020071613353936600_R13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/1071-5576(94)00053-4","article-title":"Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures.","volume":"2","author":"Andersen","year":"1995","journal-title":"J Soc Gynecol Investig"},{"key":"2020071613353936600_R14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/humrep\/den087","article-title":"A low concentration of genistein induces estrogen receptor-\u03b1 and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells.","volume":"23","author":"Di","year":"2008","journal-title":"Hum Reprod"},{"key":"2020071613353936600_R15","first-page":"236","article-title":"Structure and origin of uterine and extragenital fibroids induced experimentally in the guinea pig by prolonged administration of estrogens.","volume":"1","author":"Lipschu\u0308tz","year":"1941","journal-title":"Cancer Res"},{"key":"2020071613353936600_R16","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone.","volume":"82","author":"Matsuo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613353936600_R17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2005-2379","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613353936600_R18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis.","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2020071613353936600_R19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"2020071613353936600_R20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000292738","article-title":"Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis.","volume":"34","author":"Lamminen","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"2020071613353936600_R21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9378(89)80046-8","article-title":"Mitotic activity in uterine leiomyomas during the menstrual cycle.","volume":"160","author":"Kawaguchi","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613353936600_R22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004347-198506000-00001","article-title":"The effect of progestins on the mitotic activity of uterine fibromyomas.","volume":"4","author":"Tiltman","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"2020071613353936600_R23","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.1064829","article-title":"Taking cell-matrix adhesions to the third dimension.","volume":"294","author":"Cukierman","year":"2001","journal-title":"Science"},{"key":"2020071613353936600_R24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35099066","article-title":"Transmembrane cross talk between the extracellular matrix-cytoskeleton cross talk.","volume":"2","author":"Geiger","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2020071613353936600_R25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/molehr\/gal018","article-title":"In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells.","volume":"12","author":"Zaitseva","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"2020071613353936600_R26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/molehr\/2.11.823","article-title":"Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.","volume":"2","author":"Severino","year":"1996","journal-title":"Mol Hum Reprod"},{"key":"2020071613353936600_R27","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613353936600_R28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajog.2008.02.010","article-title":"Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice.","volume":"199","author":"Hassan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613353936600_R29","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/labinvest.3700335","article-title":"An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.","volume":"85","author":"Wang","year":"2005","journal-title":"Lab Invest"},{"key":"2020071613353936600_R30","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R \u03b3 null mice engrafted with mobilized human hemopoietic stem cells.","volume":"174","author":"Shultz","year":"2005","journal-title":"J Immunol"},{"key":"2020071613353936600_R31","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.166.3.2080","article-title":"Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains.","volume":"166","author":"Bebo Jr","year":"2001","journal-title":"J Immunol"},{"key":"2020071613353936600_R32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/153537020322800310","article-title":"Inhibitory effects of progesterone on plasma membrane fluidity and tumorigenic potential of ovarian epithelial cancer cells.","volume":"228","author":"McDonnel","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"2020071613353936600_R33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2004.09.011","article-title":"Effects of progesterone on ovarian tumorigenesis in xenografted mice.","volume":"221","author":"McDonnel","year":"2005","journal-title":"Cancer Lett"},{"key":"2020071613353936600_R34","doi-asserted-by":"crossref","first-page":"R1415","DOI":"10.1152\/ajpregu.2000.278.6.R1415","article-title":"Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse","volume":"278","author":"Gross","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071613353936600_R35","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-04-3087","article-title":"Progesterone receptor in non-small cell lung cancer\u2014a potent prognostic factor and possible target for endocrine therapy.","volume":"65","author":"Ishibashi","year":"2005","journal-title":"Cancer Res"},{"key":"2020071613353936600_R36","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells.","volume":"92","author":"Yin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613353936600_R37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-0436.2005.00033.x","article-title":"The activation function-1 domain of estrogen receptor \u03b1 in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.","volume":"73","author":"Kurita","year":"2005","journal-title":"Differentiation"},{"key":"2020071613353936600_R38","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/1097-0142(19921015)70:8<2051::AID-CNCR2820700806>3.0.CO;2-1","article-title":"Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice.","volume":"70","author":"Hann","year":"1992","journal-title":"Cancer"},{"key":"2020071613353936600_R39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1095\/biolreprod64.1.272","article-title":"Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-\u03b1 knockout mouse.","volume":"64","author":"Kurita","year":"2001","journal-title":"Biol Reprod"},{"key":"2020071613353936600_R40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31818aa930","article-title":"Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial.","volume":"112","author":"Carbonell Esteve","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2020071613353936600_R41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2020071613353936600_R42","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.","volume":"24","author":"Engman","year":"2009","journal-title":"Hum Reprod"},{"key":"2020071613353936600_R43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.","volume":"22","author":"Williams","year":"2007","journal-title":"Hum Reprod"},{"key":"2020071613353936600_R44","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.","volume":"93","author":"Wilkens","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613353936600_R45","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J"},{"key":"2020071613353936600_R46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005287.pub3","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","author":"Wu","year":"2007"},{"key":"2020071613353936600_R47","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0015-0282(03)00261-9","article-title":"A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.","volume":"79","author":"Donnez","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071613353936600_R48","first-page":"671","article-title":"Pregnancy-related changes in the size of uterine leiomyomas.","volume":"51","author":"Neiger","year":"2006","journal-title":"J Reprod Med"},{"key":"2020071613353936600_R49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7863\/jum.1992.11.10.511","article-title":"Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study.","volume":"11","author":"Rosati","year":"1992","journal-title":"J Ultrasound Med"},{"key":"2020071613353936600_R50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jmig.2006.04.003","article-title":"Volume change of uterine myomas during pregnancy: do myomas really grow?","volume":"13","author":"Hammoud","year":"2006","journal-title":"J Minim Invasive Gynecol"},{"key":"2020071613353936600_R51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0015-0282(98)00208-8","article-title":"A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.","volume":"70","author":"Marshall","year":"1998","journal-title":"Fertil Steril"},{"key":"2020071613353936600_R52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.EDE.0000054360.61254.27","article-title":"Why is parity protective for uterine fibroids?","volume":"14","author":"Baird","year":"2003","journal-title":"Epidemiology"},{"key":"2020071613353936600_R53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajog.2004.06.066","article-title":"Shunting the intervillous space: new concepts in human uteroplacental vascularization.","volume":"192","author":"Schaaps","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613353936600_R54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00001648-199607000-00018","article-title":"Reproductive factors and risk of uterine fibroids.","volume":"7","author":"Parazzini","year":"1996","journal-title":"Epidemiology"},{"key":"2020071613353936600_R55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/aje\/153.1.20","article-title":"Risk factors for uterine fibroids among women undergoing tubal sterilization.","volume":"153","author":"Chen","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2020071613353936600_R56","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/carcin\/22.12.2049","article-title":"Protective effect of pregnancy for development of uterine leiomyoma.","volume":"22","author":"Walker","year":"2001","journal-title":"Carcinogenesis"},{"key":"2020071613353936600_R57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmig.2005.01.022","article-title":"Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas.","volume":"12","author":"Eisinger","year":"2005","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/6\/2433\/9008175\/endo2433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/6\/2433\/9008175\/endo2433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:11:48Z","timestamp":1594930308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/6\/2433\/2456771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,7]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2009-1225","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3692959.3416058","asserted-by":"object"}]},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,7]]}}}